Skip to main content

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

May 2013 - FRMC

05/17/2013
San Diego—For the first time in 60 years, prescription drug sales declined in the United States in 2012, falling by 1%. At the same time, the number of prescriptions filled increased only 1.2% last year, according to data from IMS Health, a...
San Diego—For the first time in 60 years, prescription drug sales declined in the United States in 2012, falling by 1%. At the same time, the number of prescriptions filled increased only 1.2% last year, according to data from IMS Health, a...
San Diego—For the first time in...
05/17/2013
First Report Managed Care
05/17/2013
San Diego—The FDA approvals of boceprevir and telaprevir in 2011 were seen as breakthroughs in treating patients with hepatitis C. The oral drugs are protease inhibitors used in combination with pegylated interferon and ribavirin. These...
San Diego—The FDA approvals of boceprevir and telaprevir in 2011 were seen as breakthroughs in treating patients with hepatitis C. The oral drugs are protease inhibitors used in combination with pegylated interferon and ribavirin. These...
San Diego—The FDA approvals of...
05/17/2013
First Report Managed Care
05/17/2013
Edith Rosato, RPh, began her position as AMCP’s chief executive officer in October 2011, coinciding with unprecedented change in the healthcare industry. Economic conditions were weak, and companies were preparing for provisions in the...
Edith Rosato, RPh, began her position as AMCP’s chief executive officer in October 2011, coinciding with unprecedented change in the healthcare industry. Economic conditions were weak, and companies were preparing for provisions in the...
Edith Rosato, RPh, began her...
05/17/2013
First Report Managed Care

Advertisement

Advertisement

Advertisement